leadf
logo-loader
viewEmpower Clinics Inc.

Full interview: Empower Clinics looks to move forward on advancement of psilocybin research

EMPOWER CLINICS INC. (CSE: CBDT-OTC: EPWCF) Chairman and CEO Steven McAuley joined Steve Darling from Proactive Vancouver to discuss the company creating a subsidiary company dedicated to the advancement of psilocybin research and patient care.

McAuley tells Proactive why he feels they are uniquely positioned to lead the charge on this and also some of the conditions they would be treating.

Quick facts: Empower Clinics Inc.

Price: 0.08 CAD

CSE:CBDT
Market: CSE
Market Cap: $15.7 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Empower Clinics Inc. named herein, including the promotion by the Company of Empower Clinics Inc. in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Empower Clinics Kai Medical Lab will launch FDA approved saliva based tests...

Empower Clinics (CSE: CBDT- OTCQB: EPWCF) Chairman and CEO Steven McAuley joined Steve Darling to bring news their subsidiary Kai Medical Labs will be launching an FDA approved, at home/work saliva COVID-19 Saliva Test on December 15th. McAuley telling Proactive this test is simple and easy...

16 hours, 46 minutes ago

2 min read